I am not happy but still look forward to being happy in the

New Post Public Reply Private Reply Replies (0) Message Board
Jaythree nucwarrant #22002
576
I am not happy but still look forward to being happy in the future. Neither you nor I nor Banafee nor Drugmanrx or anyone else on this site know what is going to happen. We do know that QMC is still in business and are still working on getting a major patent and are working to get approvals for test strips for TBI and long covid and possibly others.
We know this because Podesta posted 4th quarter lobbying results for 2022 and did not file a report disclosing the end of the relationship. Podesta is a professional organization and if the relationship had ended, I think they would do their job and post that information. I also know that the alphabet organizations of the Federal Government have been bombarded with tons of applications from many other organizations big and small since the beginning of covid and that has slowed the processes to a snail's pace. That includes the U S Patent and Trademark office.
Patience is difficult but is key. I am struggling but am being patience.
From Proplublica site:
Quantum Materials Corp.
MORE RECORDS

LOBBYING FIRM
PODESTA.COM
MORE RECORDS

Issues related to manufacturing and design of nanotechnology that pertain to point of care and home based Covid testing.
Duration: January 18, 2022 to present

General Issues: Health Issues

Spending: about $400,000 (But it's complicated. Here's why.)

Agencies lobbied since 2022: Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP)

Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Anthony Podesta n/a
Elizabeth Demaree n/a
Helen Hagerty n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading